Emri, S. Et Al. 2017. Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma. JOURNAL OF THORACIC ONCOLOGY , vol.12, no.1 .

Emri, S., Dikmen, G., SARINÇ ULAŞLI, S., Esendagli, D., Yilmaz, U., ŞİMŞEK ÖZEK, N., ... Severcan, F.(2017). Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma. JOURNAL OF THORACIC ONCOLOGY , vol.12, no.1.

Emri, Salih Et Al. "Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma," JOURNAL OF THORACIC ONCOLOGY , vol.12, no.1, 2017

Emri, Salih Et Al. "Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma." JOURNAL OF THORACIC ONCOLOGY , vol.12, no.1, 2017

Emri, S. Et Al. (2017) . "Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma." JOURNAL OF THORACIC ONCOLOGY , vol.12, no.1.

@article{article, author={Salih Emri Et Al. }, title={Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma}, journal={JOURNAL OF THORACIC ONCOLOGY}, year=2017}